Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 655,918
  • Shares Outstanding, K 60,677
  • Annual Sales, $ 0 K
  • Annual Income, $ -46,340 K
  • EBIT $ -51 M
  • EBITDA $ -51 M
  • 60-Month Beta 1.56
  • Price/Sales 51.00
  • Price/Cash Flow N/A
  • Price/Book 10.65

Options Overview Details

View History
  • Implied Volatility 73.27% ( -8.19%)
  • Historical Volatility 91.12%
  • IV Percentile 43%
  • IV Rank 26.16%
  • IV High 180.81% on 07/08/24
  • IV Low 35.17% on 10/03/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 2,316
  • Volume Avg (30-Day) 1,115
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 29,014
  • Open Int (30-Day) 30,664

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.79 +38.77%
on 12/31/24
11.00 -1.73%
on 01/08/25
+1.31 (+13.79%)
since 12/06/24
3-Month
7.79 +38.77%
on 12/31/24
13.85 -21.95%
on 10/29/24
+1.14 (+11.79%)
since 10/08/24
52-Week
2.89 +274.05%
on 02/08/24
13.85 -21.95%
on 10/29/24
+7.20 (+199.45%)
since 01/08/24

Most Recent Stories

More News
CorMedix Stock Rises on Q4 Preliminary Sales Beating Estimates

Shares of CorMedix CRMD rose nearly 30% on Tuesday after management announced fourth-quarter and full-year 2024 preliminary sales figures.CorMedix’s Preliminary Sales Figures Beat EstimatesCorMedix reported...

CTMX : 0.9828 (-3.65%)
PBYI : 3.55 (-5.08%)
CSTL : 32.72 (+1.71%)
CRMD : 10.81 (+4.95%)
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

CRMD : 10.81 (+4.95%)
CorMedix Inc. to Join Nasdaq Biotechnology Index Effective December 23, 2024

CorMedix Inc. will join the Nasdaq Biotechnology Index effective December 23, 2024, reflecting its market performance.Quiver AI SummaryCorMedix Inc., a biopharmaceutical company focusing on treatments...

CRMD : 10.81 (+4.95%)
CorMedix Inc. Added to Nasdaq Biotechnology Index

CRMD : 10.81 (+4.95%)
CorMedix Inc. Commends CMS Policy Changes Expanding Access to Innovative Therapies for Hemodialysis Patients

CorMedix highlights CMS policy changes increasing access to innovative therapies for hemodialysis patients starting January 2025.Quiver AI SummaryCorMedix Inc. has announced the recent policy changes by...

CRMD : 10.81 (+4.95%)
Best Momentum Stocks to Buy for November 8th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8:CorMedix Inc. CRMD: This biopharmaceutical company has a Zacks Rank #1 and witnessed...

SPPJY : 2.6000 (-6.34%)
CRMD : 10.81 (+4.95%)
FFIC : 14.50 (+0.42%)
New Strong Buy Stocks for November 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Sappi Limited SPPJY: This wood fiber-based renewable resources company has seen the Zacks Consensus Estimate for its current year...

NTGR : 26.95 (-1.39%)
SPPJY : 2.6000 (-6.34%)
AACAY : 4.5120 (-7.26%)
CRMD : 10.81 (+4.95%)
FFIC : 14.50 (+0.42%)
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

CRMD : 10.81 (+4.95%)
CorMedix (CRMD) Q3 2024 Earnings Call Transcript

CRMD earnings call for the period ending September 30, 2024.

CRMD : 10.81 (+4.95%)

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 12.06
2nd Resistance Point 11.53
1st Resistance Point 11.17
Last Price 10.81
1st Support Level 10.28
2nd Support Level 9.75
3rd Support Level 9.39

See More

52-Week High 13.85
Last Price 10.81
Fibonacci 61.8% 9.66
Fibonacci 50% 8.37
Fibonacci 38.2% 7.08
52-Week Low 2.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar